RxDoctor Payments Data

Jose Rodriguez-Garcia, MD

Family Medicine · Glendale, AZNPI 1396271912

Payments from drug & device makers

$12,368in general payments, 2019–2025

Across 215 payments — averaging $57.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$10K
  • Viiv Healthcare Company$1K
  • Merck$573
  • Theratechnologies Inc.$269
  • Napo Pharmaceuticals Inc$152
  • Pfizer$126
  • plus $584 from 11 others

What the payments were for

  • Consulting fees$5,94048%
  • Travel & lodging$1,29010%
  • Food & beverage$5,13842%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,368 in reported general payments places this provider in the 90th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$7,224
Medicare patients
29
Services billed
73

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala134$554,307
Egrifta SvTesamorelin Acetate19$247,566
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf26$170,602
PrezcobixDarunavir/Cobicistat49$142,544
TivicayDolutegravir Sodium45$128,076
DescovyEmtricitabine/Tenofov Alafenam43$112,089
GenvoyaElviteg/Cob/Emtri/Tenof Alafen23$106,213
DovatoDolutegravir Sodium/Lamivudine30$92,253
IsentressRaltegravir Potassium34$70,369
OdefseyEmtricitab/Rilpiviri/Tenof Ala18$64,305
FarxigaDapagliflozin Propanediol15$18,298
OzempicSemaglutide11$15,424
Maraviroc11$13,584
Etravirine12$13,179
Testosterone15$2,192

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Descovy, Genvoya$9,590$772,608200 claims
Theratechnologies Inc.Egrifta Sv$269$247,56619 claims
Viiv Healthcare CompanyTivicay, Dovato$1,073$220,32975 claims
Johnson & JohnsonPrezcobix$100$142,54449 claims
MerckIsentress$573$70,36934 claims
Novo NordiskOzempic$14$15,42411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Glendale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →